body { -webkit-animation: none; -moz-animation: none; -ms-animation: none; animation: none }

EXPLORE!

Ozenoxacin cream approved for use in impetigo in infants

2005 Views

eMediNexus 16 December 2017

The US Food and Drug Administration (FDA) has approved ozenoxacin cream 1% for impetigo in patients aged 2 months and older. A quinolone antimicrobial, ozenoxacin cream is to be applied twice daily for 5 days.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.